Inhibition of the metallo-beta-lactamase produced from Serratia marcescens by thiol compounds. 1997

M Goto, and T Takahashi, and F Yamashita, and A Koreeda, and H Mori, and M Ohta, and Y Arakawa
Faculty of Pharmaceutical Sciences, Kumamoto University, Japan.

Low molecular weight thiol compounds have been found to be strong inhibitors of metallo-beta-lactamase (IMP-1) produced by Serratia marcescens TN9106, which was expressed by Echerichia coli JM109 cells. Mercaptoacetic acid and 2-mercaptopropionic acid strongly and competitively inhibited IMP-1 with Ki of 0.23 and 0.19 microM, respectively. 2-Mercaptoethanol reversibly inhibited IMP-1 but did not show simple competitive inhibition.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D001426 Bacterial Proteins Proteins found in any species of bacterium. Bacterial Gene Products,Bacterial Gene Proteins,Gene Products, Bacterial,Bacterial Gene Product,Bacterial Gene Protein,Bacterial Protein,Gene Product, Bacterial,Gene Protein, Bacterial,Gene Proteins, Bacterial,Protein, Bacterial,Proteins, Bacterial
D001618 beta-Lactamases Enzymes found in many bacteria which catalyze the hydrolysis of the amide bond in the beta-lactam ring. Well known antibiotics destroyed by these enzymes are penicillins and cephalosporins. beta-Lactamase,beta Lactamase,beta Lactamases
D012706 Serratia marcescens A species of gram-negative, facultatively anaerobic, rod-shaped bacteria found in soil, water, food, and clinical specimens. It is a prominent opportunistic pathogen for hospitalized patients.
D013438 Sulfhydryl Compounds Compounds containing the -SH radical. Mercaptan,Mercapto Compounds,Sulfhydryl Compound,Thiol,Thiols,Mercaptans,Compound, Sulfhydryl,Compounds, Mercapto,Compounds, Sulfhydryl
D065093 beta-Lactamase Inhibitors Endogenous substances and drugs that inhibit or block the activity of BETA-LACTAMASES. beta Lactamase Inhibitor,beta Lactamase Inhibitors,beta-Lactamase Inhibitor,beta Lactamase Antagonists,Antagonists, beta Lactamase,Inhibitor, beta Lactamase,Inhibitor, beta-Lactamase,Inhibitors, beta Lactamase,Inhibitors, beta-Lactamase,Lactamase Antagonists, beta,Lactamase Inhibitor, beta,Lactamase Inhibitors, beta

Related Publications

M Goto, and T Takahashi, and F Yamashita, and A Koreeda, and H Mori, and M Ohta, and Y Arakawa
January 1995, Microbiology and immunology,
M Goto, and T Takahashi, and F Yamashita, and A Koreeda, and H Mori, and M Ohta, and Y Arakawa
March 2013, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
M Goto, and T Takahashi, and F Yamashita, and A Koreeda, and H Mori, and M Ohta, and Y Arakawa
October 1981, The Journal of antibiotics,
M Goto, and T Takahashi, and F Yamashita, and A Koreeda, and H Mori, and M Ohta, and Y Arakawa
November 1986, The Biochemical journal,
M Goto, and T Takahashi, and F Yamashita, and A Koreeda, and H Mori, and M Ohta, and Y Arakawa
April 1995, Antimicrobial agents and chemotherapy,
M Goto, and T Takahashi, and F Yamashita, and A Koreeda, and H Mori, and M Ohta, and Y Arakawa
November 1997, Antimicrobial agents and chemotherapy,
M Goto, and T Takahashi, and F Yamashita, and A Koreeda, and H Mori, and M Ohta, and Y Arakawa
March 2002, Diagnostic microbiology and infectious disease,
M Goto, and T Takahashi, and F Yamashita, and A Koreeda, and H Mori, and M Ohta, and Y Arakawa
January 2000, Journal of clinical microbiology,
M Goto, and T Takahashi, and F Yamashita, and A Koreeda, and H Mori, and M Ohta, and Y Arakawa
September 1995, Antimicrobial agents and chemotherapy,
M Goto, and T Takahashi, and F Yamashita, and A Koreeda, and H Mori, and M Ohta, and Y Arakawa
March 1999, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy,
Copied contents to your clipboard!